Gaois

Search direction

Search mode

Filter results

Collections

107 results in 57 documents

  1. #1890859

    Is galar tógálach é an galar coróinvíris (COVID-19) arb é coróinvíreas nua-aimsithe is cúis leis.

    Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

    Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19)

  2. #2055513

    Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);

    Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);

    Regulation (EU) 2021/821 of the European Parliament and of the Council of 20 May 2021 setting up a Union regime for the control of exports, brokering, technical assistance, transit and transfer of dual-use items (recast)

  3. #2055515

    Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);

    Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);

    Regulation (EU) 2021/821 of the European Parliament and of the Council of 20 May 2021 setting up a Union regime for the control of exports, brokering, technical assistance, transit and transfer of dual-use items (recast)

  4. #2273256

    Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);

    Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);

    Commission Delegated Regulation (EU) 2022/1 of 20 October 2021 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  5. #2273258

    Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);

    Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);

    Commission Delegated Regulation (EU) 2022/1 of 20 October 2021 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  6. #2697057

    Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);

    Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);

    Commission Delegated Regulation (EU) 2023/66 of 21 October 2022 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  7. #2697059

    Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);

    Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);

    Commission Delegated Regulation (EU) 2023/66 of 21 October 2022 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  8. #2822171

    Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);

    Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);

    Commission Delegated Regulation (EU) 2023/996 of 23 February 2023 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  9. #2822173

    Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);

    Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);

    Commission Delegated Regulation (EU) 2023/996 of 23 February 2023 amending Regulation (EU) 2021/821 of the European Parliament and of the Council as regards the list of dual-use items

  10. #1886743

    Is é atá i ngéarshiondróm trom riospráide, choróinvíreas-2 (SARS-CoV-2), arb é is cúis leis an ngalar coróinvíris, ar thug an Eagraíocht Dhomhanda Sláinte (EDS) COVID-19 air, tréithchineál nua coróinvíris nár aithníodh cheana sa duine.

    The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes the coronavirus disease named COVID-19 by the World Health Organization (WHO), is a new strain of coronavirus not previously identified in humans.

    Council Regulation (EU) 2020/672 of 19 May 2020 on the establishment of a European instrument for temporary support to mitigate unemployment risks in an emergency (SURE) following the COVID-19 outbreak

  11. #2043831

    Is galar tógálach é galar coróinvíris (COVID-19) arb é coróinvíreas nua-aimsithe (SARS-CoV-2) is cúis leis.

    Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus (SARS-CoV-2).

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  12. #2043856

    Staid na paindéime maidir leis an bhfliú daonna agus maidir leis an gcoróinvíreas daonna

    Pandemic situation with respect to human influenza and human coronavirus

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  13. #2201715

    FRA,Coronavirus pandemic in the EU-impact on Roma and Travellers [Paindéim Choróinvíris san Aontas-tionchar ar na Romaigh agus ar an Lucht Siúil], 2020.

    FRA, Coronavirus pandemic in the EU-impact on Roma and Travellers, 2020.

    PROPOSAL FOR A JOINT EMPLOYMENT REPORT FROM THE COMMISSION AND THE COUNCIL

  14. #2632752

    an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII) agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII+) agus an pacáiste REACT-EU.

    the Coronavirus Response Investment Initiative (CRII), the Coronavirus Response Investment Initiative Plus (CRII+) and REACT-EU package.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Report on Competition Policy 2021

  15. #2637649

    https://ec.europa.eu/info/live-work-travel-eu/coronavirus‑response/public-health/eu-vaccines‑strategy_ga.

    https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/eu-vaccines-strategy_en.

    COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU response to COVID-19: preparing for autumn and winter 2023

  16. #3056386

    Is iad na figiúirí príomha maidir le méid na n-acmhainní a slógadh faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII) agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII+):

    The headline figures on the volume of resources mobilised under the Coronavirus Response Investment Initiative (CRII) and the Coronavirus Response Investment Initiative Plus (CRII+):

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  17. #3056921

    Na figiúirí príomha () maidir le méid na n-acmhainní a slógadh faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus, is mar a leanas atá siad:

    The headline figures () on the volume of resources mobilised under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus are as follows:

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  18. #2043857

    De mhaolú ar Chaibidlí I, II, IIa agus III, i gcás ina n-aithneoidh an Eagraíocht Dhomhanda Sláinte nó an tAontas go cuí go bhfuil staid na paindéime ann i ndáil leis an bhfliú daonna nó leis an gcoróinvíreas daonna, faoi chreat Chinneadh Uimh. 1082/2013/AE ó Pharlaimint na hEorpa agus ón gComhairle, féadfaidh na húdaráis ábhartha, nó i gcás údaruithe margaíochta láraithe, féadfaidh an Coimisiún, i gcás ina bhfuil sonraí cógaisíochta, neamhchliniciúla nó cliniciúla in easnamh, glacadh go heisceachtúil agus go sealadach le hathrú ar na téarmaí a bhaineann le húdarú margaíochta le haghaidh vacsaín fhliú dhaonna nó vacsaín choróinvíris dhaonna.

    By way of derogation from Chapters I, II, IIa and III, where a pandemic situation with respect to human influenza or human coronavirus is duly recognised by the World Health Organization or by the Union in the framework of Decision No 1082/2013/EU of the European Parliament and of the Council, the relevant authorities, or in the case of centralised marketing authorisations, the Commission may, where certain pharmaceutical, non-clinical or clinical data are missing, exceptionally and temporarily accept a variation to the terms of a marketing authorisation for a human influenza vaccine or a human coronavirus vaccine.

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  19. #2073951

    An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de ghéarshiondróm trom riospráide, coróinvíreas 2 (SARS-CoV-2), arb é is cúis le galar choróinvíreas 2019 (COVID-19).

    On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).

    Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic (Text with EEA relevance)

  20. #2074400

    An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de choróinvíreas géarshiondróim throm riospráide 2 (SARS-CoV-2), arb é is cúis le galar an choróinvíris 2019 (COVID-19).

    On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).

    Regulation (EU) 2021/954 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) with regard to third-country nationals legally staying or residing in the territories of Member States during the COVID-19 pandemic (Text with EEA relevance)

  21. #2199654

    Ag tús ghéarchéim COVID-19, le cistí comhtháthaithe soláthraíodh freagairt thapa faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII agus CRII+), rud a chuir le méadú glan ó cháin os cionn EUR 11 billiún le haghaidh bearta fostaíochta agus bearta cúraim sláinte faoi mhí na Samhna 2021.

    At the start of the COVID-19 crisis, cohesion funds provided a rapid response under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus (CRII and CRII+), resulting in a net increase of over EUR 11 billion for employment and healthcare measures by November 2021.

    PROPOSAL FOR A JOINT EMPLOYMENT REPORT FROM THE COMMISSION AND THE COUNCIL

  22. #2265729

    An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de choróinvíreas nua, arb é is cúis le galar choróinvíreas 2019 (COVID-19).

    On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of novel coronavirus, which causes Coronavirus disease 2019 (COVID-19).

    Council Recommendation (EU) 2022/107 of 25 January 2022 on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475 (Text with EEA relevance)

  23. #2265999

    An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda den choróinvíreas nua, atá ina cúis le galar Choróinvíreas 2019 (COVID-19).

    On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of novel coronavirus, which causes Coronavirus disease 2019 (COVID-19).

    Council Recommendation (EU) 2022/108 of 25 January 2022 amending Recommendation (EU) 2020/1632 as regards a coordinated approach to facilitate safe travel during the COVID-19 pandemic in the Schengen area (Text with EEA relevance)

  24. #3056379

    In 2022, lean na Ballstáit d’úsáid a bhaint as an tsolúbthacht a mhol an Coimisiún in 2020 chun raon feidhme na gníomhaíochta a leathnú ionas go mbeadh bearta lena dtabharfaí tacaíocht don fhreagairt sláinte poiblí sna Ballstáit incháilithe freisin, agus chun athchlárú a spreagadh in earnálacha eile dá ngeilleagair, ach solúbthacht eisceachtúil á soláthar i gcomhthráth i ndáil leis na cistí ón mbeartas comhtháthaithe a úsáid faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus.

    In 2022, Member States continued to use the flexibilities proposed by the Commission in 2020 to broaden the scope of action so that measures supporting the public health response in Member States are also eligible, and to encourage reprogramming in other sectors of their economy, while providing exceptional flexibility for the use of the cohesion policy funds under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  25. #3056381

    Go foriomlán, tá 239 leasú ar na cláir bheartais comhtháthaithe atá ann cheana iarrtha ag 25 Bhallstát agus ag an Ríocht Aontaithe ag úsáid an tsolúbthacht a thairgtear leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus ().

    In all, 25 Member States and the United Kingdom have requested 239 amendments to their existing cohesion policy programmes using the flexibilities offered by the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus ().

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  26. #3056395

    Comhlánaíodh na bearta freagartha géarchéime agus réitigh géarchéime faoin Tionscnamh Infheistíochta um an bhFreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta um an bhFreagairt ar an gCoróinvíreas Plus le hiomlán de EUR 50.6 billiún faoin gcúnamh téarnaimh le haghaidh comhtháthú agus críocha na hEorpa (REACT-EU) chun tacú le hinniúlachtaí réitigh géarchéime, lena n-áirítear bearta fostaíochta, tacaíocht do chórais chúram sláinte agus d’fhiontair bheaga agus mheánmhéide agus chun téarnamh glas, digiteach agus athléimneach an gheilleagair a ullmhú, mar shampla trí infheistíochtaí a dhéanamh in éifeachtúlacht fuinnimh, glasú uirbeach agus digitiú scoileanna agus gnólachtaí.

    The crisis-response and crisis-repair measures under Coronavirus Response Investment Initiative and Coronavirus Response Investment Initiative Plus were complemented by a total of EUR 50.6 billion under the recovery assistance for cohesion and the territories of Europe (REACT-EU) to support crisis-repair capacities, including employment measures, support to healthcare systems and small and medium-sized enterprises and prepare the green, digital and resilient recovery of the economy, for example, through investments in energy efficiency, urban greening and digitalisation of schools and businesses.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  27. #3056915

    Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus, a forlíonadh i mí Bealtaine 2020 le pacáiste an Chúnaimh Téarnaimh don Chomhtháthú agus do Chríocha na hEorpa (REACT-EU) chun tacú le hinniúlachtaí réitigh géarchéime, lena n-áirítear bearta fostaíochta, tacaíocht do chórais cúraim sláinte agus d’fhiontair bheaga agus mheánmhéide agus chun téarnamh glas, digiteach agus athléimneach an gheilleagair a ullmhú.

    the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus, which were supplemented in May 2020 with the Recovery Assistance for Cohesion and the Territories of Europe (REACT-EU) package to support crisis-repair capacities, including employment measures, support to healthcare systems and small and medium-sized enterprises and prepare the green, digital and resilient recovery of the economy.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  28. #3056917

    Go foriomlán, tá 239 leasú ar na cláir bheartais comhtháthaithe atá acu cheana iarrtha ag 25 Bhallstát agus ag an Ríocht Aontaithe ag úsáid an tsolúbthacht a thairgtear leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus.

    25 Member States and the United Kingdom have requested 239 amendments to their existing cohesion policy programmes using the flexibilities offered by the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2022

  29. #1890849

    a bhaineann le táirgí íocshláinte lena n‐úsáid ag an duine ina bhfuil orgánaigh ghéinmhodhnaithe atá beartaithe an galar coróinvíris (COVID-19) a chóireáil nó a chosc nó atá comhdhéanta díobh agus soláthar na dtáirgí sin

    on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19)

    Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19)

  30. #1943334

    An 11 Márta 2020, dhearbhaigh an Eagraíocht Dhomhanda Sláinte (EDS) gur paindéim dhomhanda a bhí i ráig an choróinvíris úrnua (COVID-19).

    On 11 March 2020, the World Health Organization (WHO) declared the novel coronavirus (COVID-19) outbreak a global pandemic.

    Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014 (Text with EEA relevance)

  31. #2041106

    D’fhéadfaí na hoibríochtaí seo a fhorfheidhmiú freisin trí mhodh cianda nuair a ghearrtar srianta nó moltaí arna n-eisiúint ag údaráis inniúla chun moill a chur le scaipeadh an choróinvíris.

    These operations may also be implemented by remote means when restrictions are imposed or recommendations issued by competent authorities to delay the spread of the coronavirus.

    Commission Delegated Regulation (EU) 2021/702 of 10 December 2020 amending Delegated Regulation (EU) 2015/2195 on supplementing Regulation (EU) No 1304/2013 of the European Parliament and of the Council on the European Social Fund, regarding the definition of standard scales of unit costs and lump sums for reimbursement of expenditure by the Commission to Member States

  32. #2043846

    De réir an chur chuige a ghlactar i leith vacsaíní in aghaidh an fhliú dhaonna, ba cheart feidhm a bheith ag na nósanna imeachta le gach vacsaín in aghaidh an choróinvíris dhaonna agus ba cheart cloí le hamchlár brostaithe.

    In line with the approach taken with human influenza vaccines, the procedures should apply to all human coronavirus vaccines and follow an accelerated timetable.

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  33. #2043868

    séiritíopa, tréithchineál, antaigin nó seicheamh códúcháin nó meascán de sheiritíopaí, de thréithchineálacha, d’antaiginí nó de sheichimh chódúcháin a ionadú i vacsaín choróinvíreas dhaonna nó a chur léi;

    replacement or addition of a serotype, strain, antigen or coding sequence or combination of serotypes, strains, antigens or coding sequences for a human coronavirus vaccine;

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  34. #2043872

    athruithe a bhaineann le séiritíopa, tréithchineál, antaigin nó seicheamh códúcháin nó meascán de sheiritíopaí, de thréithchineálacha, d’antaiginí nó de sheichimh chódúcháin a ionadú sa vacsaín choróinvíreas dhaonna nó a chur léi.”

    variations related to the replacement or addition of a serotype, strain, antigen or coding sequence or combination of serotypes, strains, antigens or coding sequences for a human coronavirus vaccine.’

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  35. #2200476

    Arna thacú le Tionscnaimh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII agus CRII+), sholáthair an Phortaingéil trealamh TF do scoláirí faoi mhíbhuntáiste agus oiliúint in inniúlachtaí digiteacha do mhúinteoirí.

    Supported by the Coronavirus Response Investment Initiatives (CRII and CRII+), Portugal has provided IT equipment to disadvantaged students and training in digital competences for teachers.

    PROPOSAL FOR A JOINT EMPLOYMENT REPORT FROM THE COMMISSION AND THE COUNCIL

  36. #2200529

    Sa tSlóivéin bhí tacaíocht do sholáthraithe na foghlama aosaigh mar chuid de dhlí (an ‘5ú pacáiste coróinvíris) le freagairt don phaindéim.

    In Slovenia support to adult learning providers was part of a law (the ‘5th coronavirus package’) to respond to the pandemic.

    PROPOSAL FOR A JOINT EMPLOYMENT REPORT FROM THE COMMISSION AND THE COUNCIL

  37. #2227494

    An 11 Márta 2020, d’fhógair an Eagraíocht Dhomhanda Sláinte (EDS) go bhféadfaí ráig ghalar an choróinvíris (COVID-19) a shaintréithriú feasta mar phaindéim.

    On 11 March 2020, the World Health Organization (WHO) declared that the outbreak of the coronavirus disease (COVID-19) could henceforth be characterised as a pandemic.

    Commission Implementing Decision (EU) 2022/137 of 28 January 2022 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Mydis in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2022) 408) (Only the English text is authentic)

  38. #2228006

    An 11 Márta 2020, d’fhógair an Eagraíocht Dhomhanda Sláinte (EDS) go bhféadfaí ráig ghalar an choróinvíris (COVID-19) a shaintréithriú feasta mar phaindéim.

    On 11 March 2020, the World Health Organization (WHO) declared that the outbreak of the coronavirus disease (COVID-19) could henceforth be characterised as a pandemic.

    Commission Implementing Decision (EU) 2022/155 of 31 January 2022 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Clinisept + Skin Disinfectant in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2022)457) (Only the English text is authentic)

  39. #2365722

    Is í an tSaoráid Téarnaimh agus Athléimneachta, a bunaíodh le Rialachán (AE) 2021/241 an 19 Feabhra 2021, an mhír lárnach de ‘Next Generation EU’, agus is é freagairt an Aontais Eorpaigh chun teacht as paindéim an choróinvíris agus a bheith níos láidre ná riamh.

    The Recovery and Resilience Facility, established by Regulation (EU) 2021/241 on 19 February 2021, is the centrepiece of “Next Generation EU”, the EU response to emerge stronger from the coronavirus pandemic.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the implementation of the Recovery and Resilience Facility

  40. #2438307

    Ar fáil ar: https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/high-quality-covid-19-testing_en

    Available at: https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/high-quality-covid-19-testing_en

    Council Recommendation (EU) 2022/2547 of 13 December 2022 amending Recommendation (EU) 2022/107 on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic (Text with EEA relevance)

  41. #2634577

    In 2021, shlóg an Coimisiún freisin EUR 123 mhilliún le haghaidh taighde ar athraithigh den choróinvíreas mar a fógraíodh i mí Aibreáin agus i gcomhréir le gorlann HERA.

    In 2021, the Commission also mobilised EUR 123 million for research on coronavirus variants as announced in April and in line with the HERA incubator.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Annual Report on Research and Technological Development Activities of the European Union and Monitoring of Horizon Europe and Horizon 2020 in 2021

  42. #2634630

    Aithníodh go sealadach san anailís na fionnachtana is tábhachtaí ar chuir cistiú T&N an Aontais leo, chomh maith le taighde ar ráigeanna an choróinvíris roimhe seo ar a mbunaítear an comhrac in aghaidh na paindéime reatha.

    The analysis tentatively identified the most important discoveries to which EU R&I funding has contributed, as well as research on past coronavirus outbreaks on which the fight against the current pandemic builds.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Annual Report on Research and Technological Development Activities of the European Union and Monitoring of Horizon Europe and Horizon 2020 in 2021

  43. #2634740

    Leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas, a bunaíodh in 2020, bhíothas in ann leas iomlán solúbtha a bhaint as na cistí uile a bhí fágtha i gcláir beartais chomhtháthaithe 2014-2020.

    The Coronavirus Response Investment Initiatives, established in 2020, allowed the fully flexible mobilisation of all the remaining funds in the 2014-2020 cohesion policy programmes.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL AND THE COURT OF AUDITORS Annual Management and Performance Report for the EU Budget - Financial Year 2021

  44. #2637398

    Agus é ag pleanáil don mheántéarma, tá an Coimisiún ag dul i gcomhar le comhpháirtithe idirnáisiúnta agus le forbróirí vacsaíní uilechoróinvíris a d’fhéadfadh a bheith ann, nó comhvacsaíní a spreagann freagairtí imdhíonachta níos leithne, níos láidre agus níos buaine.

    Planning for the medium-term, the Commission is engaging with international partners and developers of potential pan-coronavirus, or combination vaccines that elicit broader, stronger, and longer-lasting immune responses.

    COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EU response to COVID-19: preparing for autumn and winter 2023

  45. #2638461

    Leis na bearta spriocdhírithe tacaíochta fostaíochta in earnálacha íogaire, bhí fostóirí in ann fostaithe a choinneáil tar éis ghéarchéim an choróinvíris agus déantar éascaíocht do théarnamh an gheilleagair.

    The targeted employment support measures in sensitive sectors have allowed employers to retain employees following the outbreak of the coronavirus crisis and facilitate the recovery of the economy.

    COMMUNICATION FROM THE COMMISSION Enhanced Surveillance update - Greece, May 2022

  46. #2638703

    Is éard atá sa dá scéim ‘Gefyra’ scéimeanna sealadacha maidir le fóirdheontais tráthchodanna arna mbunú ag na húdaráis le haghaidh féichiúnaithe tuillmheacha nó féichiúnaithe athstruchtúraithe a ndearna an coróinvíreas difear dóibh.

    The two “Gefyra” schemes are temporary instalment subsidy schemes set up by the authorities for performing or restructured coronavirus-affected debtors.

    COMMUNICATION FROM THE COMMISSION Enhanced Surveillance update - Greece, May 2022

  47. #2646372

    Chuir an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas()an chéad chúnamh éigeandála ón Aontas Eorpach ar fáil d’Éirinn maidir le paindéim COVID-19.

    The Coronavirus Response Investment Initiative () provided the first EU emergency assistance to Ireland in relation to the COVID-19 pandemic.

    COMMISSION STAFF WORKING DOCUMENT 2022 Country Report - Ireland Accompanying the document Recommendation for a COUNCIL RECOMMENDATION on the 2022 National Reform Programme of Ireland and delivering a Council opinion on the 2022 Stability Programme of Ireland

  48. #2791974

    ina theannta sin, úsáideann an Phortaingéil an Eagraíocht Eitlíochta Sibhialta Idirnáisiúnta (ICAO - Effects of Novel Coronavirus (COVID-19) on Civil Aviation: Economic Impact Analysis, Montréal, Ceanada, 12 Eanáir 2022).

    in addition, Portugal uses International Civil Aviation Organization (ICAO - Effects of Novel Coronavirus (COVID-19) on Civil Aviation: Economic Impact Analysis, Montréal, Canada 12 January 2022).

    Commission Decision (EU) 2023/1229 of 7 June 2022 on the State aid SA.58101 (2020/C ex 2020/N) and SA.62043 (2021/C ex 2021/N) which Portugal is planning to implement for rescuing and restructuring the SATA Group (notified under document C(2022) 3816) (Only the English version is authentic) (Text with EEA relevance)

  49. #3051782

    maolú ar an gcreat rialála lena n-áirítear na Tionscnaimh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII agus CRII +), an creat státchabhrach agus gníomhachtú an chlásail éalaithe ghinearálta le haghaidh beartas fioscach;

    a relaxation of the regulatory framework including the Coronavirus Response Investment Initiatives (CRII and CRII+), the state aid framework and the activation of the general escape clause for fiscal policy;

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE ECONOMIC AND FINANCIAL COMMITTEE AND THE EMPLOYMENT COMMITTEE Report on the European instrument for Temporary Support to mitigate Unemployment Risks in an Emergency (SURE) following the COVID-19 outbreak pursuant to Article 14 of Council Regulation (EU) 2020/672 SURE after its sunset: final bi-annual report

  50. #3052142

    Athbhreithniú comparáideach ar impleachtaí socheacnamaíocha na paindéime coróinvíris (COVID-19) sna Stáit Bhaltacha.

    A comparative review of socio-economic implications of the coronavirus pandemic (COVID-19) in the Baltic States.

    REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE ECONOMIC AND FINANCIAL COMMITTEE AND THE EMPLOYMENT COMMITTEE Report on the European instrument for Temporary Support to mitigate Unemployment Risks in an Emergency (SURE) following the COVID-19 outbreak pursuant to Article 14 of Council Regulation (EU) 2020/672 SURE after its sunset: final bi-annual report